Cargando…
The Isolation and Characterization of β-Glucogallin as a Novel Aldose Reductase Inhibitor from Emblica officinalis
Diabetes mellitus is recognized as a leading cause of new cases of blindness. The prevalence of diabetic eye disease is expected to continue to increase worldwide as a result of the dramatic increase in the number of people with diabetes. At present, there is no medical treatment to delay or prevent...
Autores principales: | Puppala, Muthenna, Ponder, Jessica, Suryanarayana, Palla, Reddy, Geereddy Bhanuprakash, Petrash, J. Mark, LaBarbera, Daniel V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3317655/ https://www.ncbi.nlm.nih.gov/pubmed/22485126 http://dx.doi.org/10.1371/journal.pone.0031399 |
Ejemplares similares
-
Inhibition of Aldose Reductase by Gentiana lutea Extracts
por: Akileshwari, Chandrasekhar, et al.
Publicado: (2012) -
Inhibition of α-glucosidase, α-amylase, and aldose reductase by potato polyphenolic compounds
por: Kalita, Diganta, et al.
Publicado: (2018) -
Erythrocyte aldose reductase activity and sorbitol levels in diabetic retinopathy
por: Reddy, G. Bhanuprakash, et al.
Publicado: (2008) -
Antiglycating potential of Zingiber officinalis and delay of diabetic cataract in rats
por: Saraswat, Megha, et al.
Publicado: (2010) -
Diabetes-Independent Retinal Phenotypes in an Aldose Reductase Transgenic Mouse Model
por: Petrash, Jonathan Mark, et al.
Publicado: (2021)